Point72 Hong Kong’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-183,078
Closed -$4.64M 1515
2022
Q3
$4.64M Buy
+183,078
New +$6.42M 0.16% 157
2022
Q2
Sell
-5,909
Closed -$426K 2392
2022
Q1
$426K Buy
+5,909
New +$426K 0.01% 749
2021
Q1
Sell
-1,777
Closed -$355K 2206
2020
Q4
$355K Buy
+1,777
New +$361K 0.02% 798
2020
Q3
Sell
-10,112
Closed -$1.93M 1524
2020
Q2
$1.93M Buy
+10,112
New +$1.77M 0.21% 117
2018
Q4
Sell
-3,466
Closed -$299K 1195
2018
Q3
$299K Buy
+3,466
New +$247K 0.1% 120
2018
Q2
Sell
-378
Closed -$15K 1173
2018
Q1
$15K Sell
378
-1,215
-76% -$45.9K 0.01% 657
2017
Q4
$56K Buy
+1,593
New +$52.9K 0.04% 197
2017
Q1
Sell
-535
Closed -$9K 970
2016
Q4
$9K Sell
535
-3,565
-87% -$60.5K 0.01% 668
2016
Q3
$75K Buy
+4,100
New +$71.9K 0.04% 399

Other funds holding TDOC

Point72 Hong Kong's TDOC Position: Q4 2022 in Review

Point72 Hong Kong sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 183,078 shares — an estimated $4.64M sold.

Point72 Hong Kong first reported a position in TDOC in Q3 2016 and held it in 9 quarters. The position peaked at $4.64M in Q3 2022. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Point72 Hong Kong reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 183,078 Teladoc Health shares in Q4 2022, an estimated $4.64M.
  • Point72 Hong Kong first reported a position in Teladoc Health in Q3 2016 and held it in 9 quarters.
  • Point72 Hong Kong's Teladoc Health position peaked at $4.64M in Q3 2022.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.